Home | Welcome to Contract Pharma   
Last Updated Saturday, September 20 2014
Print

Breaking News

Related Searches:
July 28, 2010
Astellas has extended its non-exclusive license agreement through 2023 to use Regeneron's VelocImmune technology for its research programs to discover fully human monoclonal antibody product candidates.   Read More »
July 28, 2010
EMD Serono’s NDA for Cladribine Tablets has accepted for filing as a therapy for relapsing forms of multiple sclerosis (MS).  Read More »
July 28, 2010
Rave system to handle upcoming Phase II and III projects  Read More »
July 27, 2010
ICON 2Q 2Q Revenues: $224 million (+2%) 2Q Earnings: $22.9 million (flat) YTD Revenues: $442.9 million (+1%) YTD Earnings: $45.1 million (+3%) Comments: Income from operations was $25.7 million or 11.5% of revenue, compared to $29.3 mi…  Read More »
July 27, 2010
QPS Holdings, LLC has completed its acquisition of Xendo Drug Development BV (XDD).  Read More »
July 27, 2010
Colorcon, Inc. has acquired India-based Pharmaceutical Coatings Pvt. Ltd., which includes the company's full product portfolio and a new facility in Goa that is currently under construction.   Read More »
July 27, 2010
Kevin Jessing has been appointed director of Bioanalytical Services at ABC Laboratories, Inc.   Read More »
July 27, 2010
Susan Small has been appointed director of Quality Assurance for BioScreen Testing Services.   Read More »
July 27, 2010
CMC Biologics to make preclinical, early-stage COPD drug  Read More »
July 26, 2010
Eisai and Pfizer received approval from the FDA for a new once-daily, higher-dose Aricept (donepezil HCl) 23 mg tablet for the treatment of moderate-to-severe Alzheimer’s disease (AD).  Read More »
July 26, 2010
Karen Lackey has been named vice president and head of medicinal chemistry at Roche.   Read More »
July 26, 2010
Daiichi Sankyo received FDA approval of Tribenzor (olmesartan medoxomil, amlodipine, hydrochlorothiazide), a new three-in-one combination drug taken once-daily for the treatment of hypertension in patients who are not adequately controlled with other anti  Read More »
July 23, 2010
Firms to collaborate on EU patient registries and real-world studies  Read More »
July 23, 2010
Kamerud to lead NA investigator teams  Read More »
July 22, 2010
Plavix continued to lead the way, as Abilify revenues slipped and other products showed growth  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On